Mangoceuticals (MGRX) Operating Leases (2022 - 2026)

Mangoceuticals has disclosed Operating Leases across 5 years of filings, most recently posting $236965.0 for Q1 2026.

• Operating Leases for Q1 2026 came in at $236965.0, up 396.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $236965.0 (up 396.65% YoY), and the FY2025 annual result was $307822.0, up 373.85% from the prior year.
• Operating Leases came in at $236965.0 for Q1 2026 at Mangoceuticals, down from $307822.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $307822.0 in Q4 2025 to a low of $12167.0 in Q3 2024.
• The 5-year median for Operating Leases is $73235.0 (2023), against an average of $115416.3.
• Across the five-year window, Operating Leases slumped 85.07% in 2024 and surged 2316.56% in 2025, its largest moves.
• Mangoceuticals' Operating Leases stood at $128680.0 in 2022, then slumped by 49.52% to $64961.0 in 2023, then rose by 0.0% to $64962.0 in 2024, then soared by 373.85% to $307822.0 in 2025, then slipped by 23.02% to $236965.0 in 2026.
• The last three Operating Leases figures came in at $236965.0 (Q1 2026), $307822.0 (Q4 2025), and $294023.0 (Q3 2025), per Business Quant data.